CJC 1295 (No DAC) + Ipamorelin Synergistic GH Releasing Peptide Duo The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide Therapy Prescription in 2025: Your Safe Guide Pharm D Solutions, LLC Issues Voluntary Nationwide Recall of All Sterile Compounded Drugs Due to a Potential Lack of Sterility Assurance FDA